Nephrocare Healt

  • Market Cap: Small Cap
  • Industry: Healthcare Services
  • ISIN: INE428V01029
  • NSEID: NEPHROPLUS
  • BSEID: 544647
INR
531.70
4.7 (0.89%)
BSENSE

Mar 20

BSE+NSE Vol: 95.5 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Dec'25
Sep'25
Dec'24
Net Sales
259.73
245.72
197.26
Other Operating Income
0.00
0.00
0.00
Total Operating income
259.73
245.72
197.26
Raw Material Cost
58.52
54.17
49.39
Purchase of Finished goods
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
Employee Cost
43.10
42.96
32.92
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
50.67
47.93
38.01
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
46.58
36.73
32.85
Total Expenditure (Excl Depreciation)
198.87
181.79
153.17
Operating Profit (PBDIT) excl Other Income
60.86
63.93
44.09
Other Income
3.32
3.89
5.37
Operating Profit (PBDIT)
64.18
67.82
49.46
Interest
5.96
45.00
4.85
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
58.22
22.82
44.61
Depreciation
21.86
23.44
18.17
Profit Before Tax
36.36
-0.62
26.44
Tax
4.12
8.85
6.33
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
32.24
-9.47
20.11
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
32.24
-9.47
20.11
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
32.24
-9.47
20.11
Equity Capital
20.07
3.62
1.76
Face Value
10.0
10.0
10.0
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
16.06
-26.16
114.26
Diluted Earnings per share
3.35
-1.12
2.39
Operating Profit Margin (Excl OI)
23.43%
26.02%
22.35%
Gross Profit Margin
22.42%
9.29%
22.61%
PAT Margin
12.41%
-3.85%
10.19%
Public Share Holdings (%)
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Dec 2025 is 3.04% vs 12.81% in Sep 2025

stock-summary

Standalone Net Profit

QoQ Growth in quarter ended Dec 2025 is 126.07% vs -499.14% in Sep 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Dec 2025 is -2.60% vs 4.50% in Sep 2025

stock-summary

Interest

QoQ Growth in quarter ended Dec 2025 is -90.35% vs 1,107.35% in Sep 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025

Compare Quarterly Results Of Nephrocare Healt With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
259.73
195.53
64.20
32.83%
Other Operating Income
0.00
0.00
0.00
Total Operating income
259.73
195.53
64.20
32.83%
Raw Material Cost
58.52
47.07
11.45
24.33%
Purchase of Finished goods
0.00
0.04
-0.04
-100.00%
(Increase) / Decrease In Stocks
0.00
0.09
-0.09
-100.00%
Employee Cost
43.10
35.76
7.34
20.53%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
50.67
0.00
50.67
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
46.58
54.74
-8.16
-14.91%
Total Expenditure (Excl Depreciation)
198.87
137.70
61.17
44.42%
Operating Profit (PBDIT) excl Other Income
60.86
57.83
3.03
5.24%
Other Income
3.32
4.98
-1.66
-33.33%
Operating Profit (PBDIT)
64.18
62.81
1.37
2.18%
Interest
5.96
-0.09
6.05
6,722.22%
Exceptional Items
0.00
-6.16
6.16
100.00%
Gross Profit (PBDT)
58.22
56.74
1.48
2.61%
Depreciation
21.86
21.63
0.23
1.06%
Profit Before Tax
36.36
35.39
0.97
2.74%
Tax
4.12
7.34
-3.22
-43.87%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
32.24
27.77
4.47
16.10%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
32.24
27.77
4.47
16.10%
Share in Profit of Associates
0.00
0.28
-0.28
-100.00%
Minority Interest
0.00
-0.96
0.96
100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
32.24
29.01
3.23
11.13%
Equity Capital
20.07
159.16
-139.09
-87.39%
Face Value
10.00
10.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
16.06
1.82
14.24
782.42%
Diluted Earnings per share
3.35
1.81
1.54
85.08%
Operating Profit Margin (Excl OI)
23.43%
29.58%
0.00
-6.15%
Gross Profit Margin
22.42%
29.02%
0.00
-6.60%
PAT Margin
12.41%
14.35%
0.00
-1.94%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 160.66 Cr
in Dec 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Dec 2025 is 3.04% vs 12.81% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 16.24%

Quarterly - Standalone Net Profit
Standalone Net Profit 8.45 Cr
in Dec 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Dec 2025 is 126.07% vs -499.14% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 4.06%

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 22.86 Cr
in Dec 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Dec 2025 is -2.60% vs 4.50% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 1.78%

Quarterly - Interest
Interest 3.96 Cr
in Dec 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Dec 2025 is -90.35% vs 1,107.35% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 16.47%

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 14.23%
in Dec 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 has fallen from Dec 2024